Unnamed: 0,title,date,stock,sentiment
100137.0,Assembly Biosciences Appoints William Delaney As Chief Scientific Officer,2020-05-27 08:18:00-04:00,ASMB,neutral
100138.0,"Assembly Biosciences Q1 EPS $(0.760) Beats $(0.980) Estimate, Sales $4.100M Beat $3.820M Estimate",2020-05-07 16:55:00-04:00,ASMB,neutral
100139.0,Assembly Biosciences Q4 Sales $4.8M Up From $3.565M YoY,2020-03-04 16:12:00-05:00,ASMB,neutral
100140.0,58 Biggest Movers From Friday,2019-12-16 05:49:00-05:00,ASMB,neutral
100141.0,36 Stocks Moving In Friday's Mid-Day Session,2019-12-13 12:41:00-05:00,ASMB,neutral
100142.0,51 Biggest Movers From Yesterday,2019-12-13 04:12:00-05:00,ASMB,neutral
100143.0,38 Stocks Moving In Thursday's Mid-Day Session,2019-12-12 12:11:00-05:00,ASMB,neutral
100144.0,"The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win",2019-12-12 07:38:00-05:00,ASMB,positive
100145.0,13 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-12-12 07:37:00-05:00,ASMB,neutral
100146.0,18 Stocks Moving in Thursday's Pre-Market Session,2019-12-12 07:32:00-05:00,ASMB,neutral
100147.0,"A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Initial Jobless Claims, Producer Prices Data",2019-12-12 06:40:00-05:00,ASMB,neutral
100148.0,Assembly Biosciences Prices 5.15M Common Shares At $16.50/Share,2019-12-12 06:33:00-05:00,ASMB,positive
100149.0,"8 Stocks To Watch For December 12, 2019",2019-12-12 05:53:00-05:00,ASMB,neutral
100150.0,6 Stocks Moving In Wednesday's After-Hours Session,2019-12-11 16:36:00-05:00,ASMB,neutral
100151.0,Assembly Biosciences shares are trading lower after the company reported a common stock offering of no disclosed size.,2019-12-11 16:13:00-05:00,ASMB,negative
100152.0,"Assembly Biosciences Reports Offering Of Common Stock, No Size Disclosed",2019-12-11 16:03:00-05:00,ASMB,negative
100153.0,70 Biggest Movers From Yesterday,2019-11-15 05:29:00-05:00,ASMB,neutral
100154.0,58 Biggest Movers From Yesterday,2019-11-12 04:25:00-05:00,ASMB,neutral
100155.0,"The Week Ahead In Biotech: Adcom Test For Amarin's Fish Oil Pill, Agile Awaits FDA Verdict",2019-11-10 16:08:00-05:00,ASMB,positive
100156.0,"Assembly Biosciences Q3 EPS $(0.96) Down From $(0.87) YoY, Sales $4.231M Down From $4.286M YoY",2019-11-07 17:00:00-05:00,ASMB,neutral
100157.0,Assembly Biosciences Announces Thomas Russo CFO,2019-10-28 08:14:00-04:00,ASMB,neutral
100158.0,26 Stocks Moving in Monday's Pre-Market Session,2019-10-21 07:41:00-04:00,ASMB,neutral
100159.0,48 Biggest Movers From Yesterday,2019-10-18 06:55:00-04:00,ASMB,neutral
100160.0,32 Stocks Moving In Thursday's Mid-Day Session,2019-10-17 11:52:00-04:00,ASMB,neutral
100161.0,Assembly Biosciences Shares Up 17% Today; Co Announced Wednesday Safety and Antiviral Activity of Core Inhibitor Candidates In the Treatment of Chronic Hep B to be Featured in a Late Breaking Session at AASLD,2019-10-17 10:15:00-04:00,ASMB,positive
100162.0,54 Biggest Movers From Yesterday,2019-10-17 05:52:00-04:00,ASMB,neutral
100163.0,"Benzinga's Top Upgrades, Downgrades For October 16, 2019",2019-10-16 14:57:00-04:00,ASMB,positive
100164.0,44 Stocks Moving In Wednesday's Mid-Day Session,2019-10-16 12:35:00-04:00,ASMB,neutral
100165.0,"Mizuho Initiates Coverage On Assembly Biosciences with Buy Rating, Announces $20 Price Target",2019-10-16 06:53:00-04:00,ASMB,neutral
100166.0,Assembly Biosciences Option Alert: Nov 15 $15 Calls Sweep (2) near the Ask: 782 @ $0.3 vs 2872 OI; Earnings 11/7 Before Open [est] Ref=$9.29,2019-10-15 15:32:00-04:00,ASMB,positive
100167.0,"The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO",2019-10-10 07:31:00-04:00,ASMB,neutral
100168.0,Stocks That Hit 52-Week Lows On Wednesday,2019-10-09 12:55:00-04:00,ASMB,negative
100169.0,Stocks That Hit 52-Week Lows On Friday,2019-10-04 14:32:00-04:00,ASMB,negative
100170.0,Stocks That Hit 52-Week Lows On Wednesday,2019-10-02 10:55:00-04:00,ASMB,negative
100171.0,"The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data",2019-10-02 07:17:00-04:00,ASMB,positive
100172.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-01 14:35:00-04:00,ASMB,negative
100173.0,"The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines",2019-10-01 08:10:00-04:00,ASMB,negative
100174.0,Stocks That Hit 52-Week Lows On Monday,2019-09-30 11:20:00-04:00,ASMB,negative
100175.0,52 Biggest Movers From Yesterday,2019-09-19 05:18:00-04:00,ASMB,neutral
100176.0,Stocks That Hit 52-Week Lows On Wednesday,2019-09-04 11:39:00-04:00,ASMB,negative
100177.0,"The Daily Biotech Pulse: Puma Leaps, Aerie Borrows, Hepion Back In Nasdaq's Good Books",2019-09-04 07:08:00-04:00,ASMB,positive
100178.0,"The Daily Biotech Pulse: EC Nod For Bristol-Myers Squibb, Kyowa Kirin's Parkinson's Add-On Therapy Approved",2019-08-28 07:31:00-04:00,ASMB,positive
100179.0,90 Biggest Movers From Yesterday,2019-08-08 05:17:00-04:00,ASMB,neutral
100180.0,75 Stocks Moving In Wednesday's Mid-Day Session,2019-08-07 13:16:00-04:00,ASMB,neutral
100181.0,"Assembly Biosciences Names John McHutchison Pres, CEO",2019-08-07 09:14:00-04:00,ASMB,neutral
100182.0,"Assembly Biosciences Q2 EPS $(0.72) Beats $(1.15) Estimate, Sales $3.08M Miss $3.78M Estimate",2019-08-05 16:36:00-04:00,ASMB,negative
100183.0,New 52-Week Lows For Monday Morning,2019-08-05 13:16:00-04:00,ASMB,negative
100184.0,New 52-Week Lows for Tuesday Morning,2019-07-30 11:07:00-04:00,ASMB,negative
100185.0,Stocks That Managed to Breach 52-Week Lows Friday,2019-07-26 15:45:00-04:00,ASMB,negative
100186.0,"The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint",2019-07-26 07:26:00-04:00,ASMB,neutral
100187.0,Assembly Biosciences Reports First Patient Dosed With ABI-M201 In Phase 1b Trial For Mildly-To-Moderately Active Ulcerative Colitis,2019-06-27 07:24:00-04:00,ASMB,positive
100188.0,"The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership",2019-06-25 07:15:00-04:00,ASMB,neutral
100189.0,"Assembly Biosciences Q1 EPS $(1.04), Inline, Sales $3.885M Beat $3.65M Estimate",2019-05-09 17:10:00-04:00,ASMB,neutral
100190.0,44 Biggest Movers From Yesterday,2019-05-07 05:49:00-04:00,ASMB,neutral
100191.0,"The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen",2019-05-03 07:49:00-04:00,ASMB,positive
100192.0,40 Biggest Movers From Yesterday,2019-04-17 07:26:00-04:00,ASMB,neutral
100193.0,"The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives",2019-04-16 08:10:00-04:00,ASMB,neutral
100194.0,44 Biggest Movers From Yesterday,2019-04-16 05:44:00-04:00,ASMB,neutral
100195.0,34 Stocks Moving In Monday's Mid-Day Session,2019-04-15 12:16:00-04:00,ASMB,neutral
100196.0,Assembly Biosciences shares are trading lower after the company reported interim data from its phase 2a clinical trial; investors have interpreted this data as negative as mixed results show a decrease in HBeAg and HBsAg in only some individuals.,2019-04-15 09:52:00-04:00,ASMB,negative
100197.0,30 Stocks Moving In Monday's Pre-Market Session,2019-04-15 09:01:00-04:00,ASMB,neutral
100198.0,Assembly Biosciences Presents Positive Interim Data from Two Phase 2a Studies of ABI-H0731 in HBV-Infected Subjects in a Late-Breaker Oral Session at EASL 2019,2019-04-13 18:27:00-04:00,ASMB,positive
100199.0,"The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug",2019-04-11 07:48:00-04:00,ASMB,positive
100200.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts",2019-04-07 17:04:00-04:00,ASMB,neutral
100201.0,Assembly Biosciences Reports Multiple Abstracts Highlighting HBV Core Inhibitor Portfolio Accepted for Oral and Poster Presentations at EASL 2019,2019-03-27 07:10:00-04:00,ASMB,positive
100202.0,"The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs",2019-03-26 07:36:00-04:00,ASMB,positive
100203.0,"Assembly Biosciences Q4 EPS $(1.03) Misses $(0.91) Estimate, Sales $3.7M Miss $4.19M Estimate",2019-02-28 17:03:00-05:00,ASMB,negative
100204.0,55 Biggest Movers From Yesterday,2019-01-11 05:45:00-05:00,ASMB,neutral
100205.0,40 Stocks Moving In Thursday's Mid-Day Session,2019-01-10 12:44:00-05:00,ASMB,neutral
100206.0,Assembly Biosciences Announces Completion of Enrollment in Two Phase 2a Studies with ABI-H0731 for Chronic Hepatitis B Virus,2019-01-07 07:22:00-05:00,ASMB,neutral
100207.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,ASMB,neutral
100208.0,"Assembly Biosciences Q3 EPS $(0.87) Beats $(1.03) Estimate, Sales $4.286M Beat $3.08M Estimate",2018-11-08 08:57:00-05:00,ASMB,neutral
100209.0,"The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price",2018-10-25 08:03:00-04:00,ASMB,negative
100210.0,"Stocks Which Set New 52-Week Low Yesterday, October 23rd",2018-10-24 10:06:00-04:00,ASMB,negative
100211.0,"Stocks Which Set New 52-Week Low Yesterday, October 22nd",2018-10-23 09:54:00-04:00,ASMB,negative
100212.0,"Stocks Which Set New 52-Week Low Yesterday, October 11th",2018-10-12 11:30:00-04:00,ASMB,negative
100213.0,"The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program",2018-10-12 07:34:00-04:00,ASMB,negative
100214.0,"Stocks Which Set New 52-Week Low Yesterday, October 10th",2018-10-11 09:11:00-04:00,ASMB,negative
100215.0,"The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's Gene-Edited Therapy, Endra To Offer Shares",2018-10-11 07:39:00-04:00,ASMB,positive
100216.0,"Stocks Which Set New 52-Week Low Yesterday, October 9th",2018-10-10 11:01:00-04:00,ASMB,negative
100217.0,"The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares",2018-10-10 07:56:00-04:00,ASMB,positive
100218.0,"Recent Assembly Biosciences Weakness Provides Attractive Entry Point, B Riley FBR Says In Upgrade",2018-10-08 15:16:00-04:00,ASMB,neutral
100219.0,"Stocks Which Set New 52-Week Low Friday, October 5th",2018-10-08 09:27:00-04:00,ASMB,negative
100220.0,"B. Riley FBR Upgrades Assembly Biosciences to Buy, Maintains $42 Price Target",2018-10-08 08:28:00-04:00,ASMB,neutral
100221.0,45 Biggest Movers From Yesterday,2018-10-05 06:12:00-04:00,ASMB,neutral
100222.0,32 Stocks Moving In Thursday's Mid-Day Session,2018-10-04 12:36:00-04:00,ASMB,neutral
100223.0,55 Biggest Movers From Yesterday,2018-10-04 05:29:00-04:00,ASMB,neutral
100224.0,"Assembly Biosciences Q2 EPS $(1.30) Misses $(0.88) Estimate, Sales $3.2M Miss $3.5M Estimate",2018-08-08 17:00:00-04:00,ASMB,negative
100225.0,"Benzinga's Top Upgrades, Downgrades For August 8, 2018",2018-08-08 09:12:00-04:00,ASMB,positive
100226.0,"Baird Initiates Coverage On Assembly Biosciences with Outperform Rating, Announces $74 Price Target",2018-08-08 08:54:00-04:00,ASMB,neutral
100227.0,Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H0731 for the Treatment of Hepatitis B Virus Infection,2018-07-25 07:13:00-04:00,ASMB,positive
100228.0,44 Biggest Movers From Yesterday,2018-07-13 04:08:00-04:00,ASMB,neutral
100229.0,Assembly Biosciences Late Wednesday Priced $144M Common Stock Offering @$36/Share,2018-07-12 08:07:00-04:00,ASMB,neutral
100230.0,"Benzinga's Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares",2018-07-11 08:15:00-04:00,ASMB,neutral
100231.0,Assembly Biosciences Announces 3M Share Common Stock Offering,2018-07-10 16:05:00-04:00,ASMB,positive
100232.0,Assembly Biosciences Initiates Two Phase 2a Trials of ABI-H0731 for the Treatment of Hepatitis B Virus Infection,2018-07-09 07:23:00-04:00,ASMB,neutral
100233.0,36 Biggest Movers From Friday,2018-06-11 04:37:00-04:00,ASMB,neutral
100234.0,"Assembly Biosciences Q1 EPS $(0.80) Misses $(0.76) Estimate, Sales $3.6M Beat $1.88M Estimate",2018-05-07 16:07:00-04:00,ASMB,negative
100235.0,40 Biggest Movers From Friday,2018-04-16 05:19:00-04:00,ASMB,neutral
100236.0,"Benzinga's Top Analyst Calls From April 13, 2018",2018-04-13 13:09:00-04:00,ASMB,positive
100237.0,30 Stocks Moving In Friday's Mid-Day Session,2018-04-13 12:17:00-04:00,ASMB,neutral
100238.0,"Chardan: Assembly Biosciences Hep B Antiviral Data 'Positive,' But Undifferentiated From Competitor Johnson & Johnson",2018-04-13 10:31:00-04:00,ASMB,neutral
100239.0,"Benzinga's Top Upgrades, Downgrades For April 13, 2018",2018-04-13 09:28:00-04:00,ASMB,positive
100240.0,Chardan Capital Downgrades Assembly Biosciences to Neutral,2018-04-13 07:21:00-04:00,ASMB,neutral
100241.0,Assembly Biosciences Earlier Announced ABI-H0731 Phase 1b Interim Data Accepted As A Late-Breaker Poster At The International Liver Congress,2018-03-28 07:27:00-04:00,ASMB,positive
100242.0,Assembly Biosciences Announces Graham Cooper and Helen Kim CFO and COO,2018-03-12 07:19:00-04:00,ASMB,neutral
100243.0,William Blair Sees HBV Cure Market Similar to HCV with Valuation of $200B over Two Decades; Sees Consolidation in HBV Market,2018-03-06 05:58:00-05:00,ASMB,neutral
100244.0,"B. Riley Initiates Coverage On Assembly Biosciences with Neutral Rating, Announces $35.00 Price Target",2018-01-05 09:23:00-05:00,ASMB,neutral
100245.0,"Benzinga's Top Upgrades, Downgrades For November 8, 2017",2017-11-08 09:28:00-05:00,ASMB,positive
100246.0,"Jefferies Initiates Coverage On Assembly Biosciences with Buy Rating, Announces $50.00 Price Target",2017-11-08 07:27:00-05:00,ASMB,neutral
100247.0,"Assembly Biosciences Announces a Common Stock Offering, Size Not Disclosed",2017-11-01 17:01:00-04:00,ASMB,neutral
100248.0,"Companies Holding Shareholder Meetings Today Include Blue Buffalo, Activision Blizzard, Arista Networks, Assembly Biosciences, FireEye, Facebook, Ulta Beauty, Taubman Centers, Sinclair Broadcast Group, & WebMD",2017-06-01 08:32:00-04:00,ASMB,positive
100249.0,Arbutus Biopharma Taken Off Of Chardan's Sell List,2016-06-16 09:29:00-04:00,ASMB,neutral
100250.0,S-3 from Assembly Biosciences Shows Registration for $150M Mixed Securities Shelf Offering,2015-12-30 16:49:00-05:00,ASMB,positive
100251.0,Assembly Bioscience Oral Gemicel Technology Can Lower GI Tract Microbiome Targeted Delivery,2015-12-09 07:04:00-05:00,ASMB,negative
100252.0,Assembly Biosciences Prices ~5.55M Shares at $13.50/Share,2015-03-19 08:38:00-04:00,ASMB,positive
